Is there a role for type 2 CD8+ T cells in patients with steroid-resistant asthma?
- 1 September 2019
- journal article
- editorial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 144 (3) , 648-650
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL-36577, AI-77609)
- Wellcome Trust (104553/z/14/z, 211050/Z/18/z)
- National Institute for Health Research
- Oxford Biomedical Research Centre
This publication has 10 references indexed in Scilit:
- Hypoxia enhances CD8+ TC2 cell–dependent airway hyperresponsiveness and inflammation through hypoxia-inducible factor 1αJournal of Allergy and Clinical Immunology, 2019
- Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthmaMucosal Immunology, 2018
- Spectrum of T‐lymphocyte activities regulating allergic lung inflammationImmunological Reviews, 2017
- A Transcriptome-driven Analysis of Epithelial Brushings and Bronchial Biopsies to Define Asthma Phenotypes in U-BIOPREDAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Lung function decline in asthma patients with elevated bronchial CD8, CD4 and CD3 cellsEuropean Respiratory Journal, 2016
- 1,25D3 prevents CD8+Tc2 skewing and asthma development through VDR binding changes to the Cyp11a1 promoterNature Communications, 2016
- IL-6 Receptor α Defines Effector Memory CD8+ T Cells Producing Th2 Cytokines and Expanding in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2014
- CD8+ T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseasesAllergy, 2013
- Bronchial CD8 Cell Infiltrate and Lung Function Decline in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- CD4 T-Lymphocyte Activation in Asthma Is Accompanied by Increased Serum Concentrations of Interleukin-5: Effect of Glucocorticoid TherapyAmerican Review of Respiratory Disease, 1993